NovaBay Pharmaceuticals
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2000-01-01
- Employees
- 8
- Market Cap
- -
- Website
- http://www.novabay.com
- Introduction
Niobay Metals Inc is engaged in the acquisition, exploration, and evaluation of mineral properties. Its project includes the James Bay Niobium Project located in northern Ontario, Canada. Its other projects include the Crevier niobium, the tantalum project, and Foothills.
Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora
- Conditions
- Sebaceous Gland DiseasesBlepharitis
- Interventions
- Device: iLid Cleanser
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02455895
- Locations
- 🇺🇸
Turner Eye Institute, San Leandro, California, United States
🇺🇸James D. Branch, MD, Winston Salem, North Carolina, United States
🇺🇸Ophthalmic Research Consultants of Arizona, Phoenix, Arizona, United States
Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency
- Conditions
- Urinary Catheter Blockage and Encrustation
- Interventions
- First Posted Date
- 2014-05-05
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT02130518
- Locations
- 🇺🇸
Lahey Hospital and Medical Clinic, Burlington, Massachusetts, United States
🇺🇸Los Amigos Research and Education Institute, Downey, California, United States
🇺🇸VA Long Beach Healthcare System, Long Beach, California, United States
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
- Conditions
- Bacterial Conjunctivitis
- Interventions
- First Posted Date
- 2013-06-14
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT01877694
Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
- Conditions
- Impetigo
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 328
- Registration Number
- NCT01670032
- Locations
- 🇺🇸
SRCR, Inc, Bell Gardens, California, United States
🇺🇸Cyn3rgy Research, Gresham, Oregon, United States
🇺🇸Sealy Urgent Care Center, Sealy, Texas, United States
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
- Conditions
- Adenoviral Conjunctivitis
- Interventions
- Drug: NVC-422 Solution, 0.3%Drug: NVC-422 Vehicle Solution
- First Posted Date
- 2012-02-14
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT01532336
Safety and Efficacy of Topical NVC-422 Gel in Impetigo
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2011-06-07
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 129
- Registration Number
- NCT01367314
- Locations
- 🇩🇴
Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, Dominican Republic
🇩🇴Instituto Dermatológico, Santo Domingo, Dominican Republic
Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation
- Conditions
- Urinary Catheter Blockage and Encrustation
- Interventions
- Drug: NVC-422, 0.2%Drug: Sterile normal saline, 0.9%
- First Posted Date
- 2010-11-18
- Last Posted Date
- 2014-08-07
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT01243125
- Locations
- 🇺🇸
McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States
🇺🇸Kessler Institute for Rehabilitation, West Orange, New Jersey, United States
🇺🇸Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients
- Conditions
- Asymptomatic Bacteriuria
- Interventions
- First Posted Date
- 2008-10-29
- Last Posted Date
- 2011-09-12
- Lead Sponsor
- NovaBay Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT00781339
- Locations
- 🇺🇸
Michael E. Debakey V.A. Medical Center, Houston, Texas, United States